Synthesis of New Amide Linked Biphenoloxy 1,2,3-Triazoles as Antitubercular and Antimicrobial Agents

References

• Madhukar Pai, Marcel A. Behr, David Dowdy, Keertan Dheda, Maziar Divangahi, Catharina C. Boehme, Ann Ginsberg, Soumya Swaminathan, Melvin Spigelman, Haileyesus Getahun, et al. “Tuberculosis,” Nature Reviews. Disease Primers 2 (2016): 16076. doi:10.1038/nrdp.2016.76
   PubMed Web of Science ®Google Scholar
• WHO 2020. Global Tuberculosis Report 2020. World Health Organization, Geneva. http://www.who.int/tb
   Google Scholar
• S. T. Dhumal, A. R. Deshmukh, M. R. Bhosle, V. M. Khedkar, L. U. Nawale, D. Sarkar, and R. A. Mane, “Synthesis and Antitubercular Activity of New 1,3,4-Oxadiazoles Bearing Pyridyl and Thiazolyl Scaffolds,” Bioorganic & Medicinal Chemistry Letters 26, no. 15 (2016): 3646–3651. doi:10.1016/j.bmcl.2016.05.093
   PubMed Web of Science ®Google Scholar
• K. Zaman, “Tuberculosis: A Global Health Problem,” Journal of Health, Population, and Nutrition 28, no. 2 (2010): 111–113. doi:10.3329/jhpn.v28i2.4879
   PubMed Web of Science ®Google Scholar
• J. B. Bass, L. S. Farer, P. C. Hopewell, R. O'Brien, R. F. Jacobs, F. Ruben, D. E. Snider, and G. Thornton, “Treatment of Tuberculosis and Tuberculosis Infection in Adults and Children. American Thoracic Society and the Centers for Disease Control and Prevention,” American Journal of Respiratory and Critical Care Medicine 149, no. 5 (1994): 1359–1374. doi:10.1164/ajrccm.149.5.8173779
   PubMed Web of Science ®Google Scholar
• D. Dheer, V. Singh, and R. Shankar, “Medicinal Attributes of 1,2,3-Triazoles:Current Developments,” Bioorganic Chemistry 71 (2017): 30–54. doi:10.1016/j.bioorg.2017.01.010
   PubMed Web of Science ®Google Scholar
• R. Kant, D. Kumar, D. Agarwal, R. D. Gupta, R. Tilak, S. K. Awasthi, and A. Agarwal, “Synthesis of Newer 1,2,3-Triazole Linked Chalcone and Flavone Hybrid Compounds and Evaluation of Their Antimicrobial and Cytotoxic Activities,” European Journal of Medicinal Chemistry 113 (2016): 34–49. doi:10.1016/j.ejmech.2016.02.041
   PubMed Web of Science ®Google Scholar
• D. Cherupally, S. K. Buddana, S. Galande, S. Gudem, M. Koneru, R. Sistla, S. P. Reddy, and C. R. Bhimapaka, “Synthesis, Pharmacological Activities and Molecular Docking Studies of Pyrazolyltriazoles as anti-Bacterial and anti-Inflammatory Agents,” Bioorganic and Medicinal Chemistry 25 (2017): 5678–5691.
   PubMed Web of Science ®Google Scholar
• Tejshri R. Deshmukh, Smita P. Khare, Vagolu S. Krishna, Dharmarajan Sriram, Jaiprakash N. Sangshetti, Omprakash Bhusnure, Vijay M. Khedkar, and Bapurao B. Shingate, “Design and Synthesis of New Aryloxy‐Linked Dimeric 1,2,3‐Triazoles via Click Chemistry Approach: Biological Evaluation and Molecular Docking Study,” Journal of Heterocyclic Chemistry 56, no. 8 (2019): 2144–2162. doi:10.1002/jhet.3608
   Web of Science ®Google Scholar
• G. Wang, Z. Peng, J. Wang, X. Li, and J. Li, “Synthesis, in Vitro Evaluation and Molecular Docking Studies of Novel Triazine-Triazole Derivatives as Potential α-Glucosidase Inhibitors,” European Journal of Medicinal Chemistry 125 (2017): 423–429. doi:10.1016/j.ejmech.2016.09.067
   PubMed Web of Science ®Google Scholar
• S. T. Dhumal, A. R. Deshmukh, K. R. Kharat, B. R. Sathe, S. S. Chavan, and R. A. Mane, “Copper Fluorapatite Assisted Synthesis of New 1,2,3-Triazoles Bearing Benzothiazolyl Moiety and Their Antibacterial and Anticancer Activities,” New Journal of Chemistry 43, no. 20 (2019): 7663–7673. doi:10.1039/C9NJ00377K
   Web of Science ®Google Scholar
• A. Krajczyk, K. Kulinska, T. Kulinski, B. L. Hurst, C. W. Day, D. F. Smee, T. Ostrowski, P. Januszczyk, and J. Zeidler, “Antivirally Active Ribavirin Analogues-4,5-Disubstituted 1,2,3-Triazole Nucleosides: Biological Evaluation against Certain Respiratory Viruses and Computational Modelling,” Antiviral Chemistry & Chemotherapy 23, no. 4 (2014): 161–171. doi:10.3851/IMP2564
   PubMedGoogle Scholar
• Y. H. Lau, P. J. Rutledge, M. Watkinson, and M. H. Todd, “Chemical Sensors That Incorporate Click-Derived Triazoles,” Chemical Society Reviews 40, no. 5 (2011): 2848–2866. doi:10.1039/c0cs00143k
   PubMed Web of Science ®Google Scholar
• S. G. Agalave, S. R. Maujan, and V. S. Pore, “Click Chemistry:1,2,3-Triazoles as Pharmacophores,” Chemistry, an Asian Journal 6, no. 10 (2011): 2696–2718. doi:10.1002/asia.201100432
   PubMed Web of Science ®Google Scholar
• N. G. Aher, V. S. Pore, N. N. Mishra, A. Kumar, P. K. Shukla, A. Sharma, and M. K. Bhat, “Synthesis and Antifungal Activity of 1,2,3-Triazole Containing Fluconazole Analogues,” Bioorganic & Medicinal Chemistry Letters 19, no. 3 (2009): 759–763. doi:10.1016/j.bmcl.2008.12.026
   PubMed Web of Science ®Google Scholar
• B. Zhou, Y. He, X. Zhang, J. Xu, Y. Luo, Y. Wang, S. G. Franzblau, Z. Yang, R. J. Chan, Y. Liu, et al. “Targeting mycobacterium Protein Tyrosine Phosphatase B for Antituberculosis Agents,” Proceedings of the National Academy of Sciences of the United States of America 107, no. 10 (2010): 4573–4578. doi:10.1073/pnas.0909133107
   PubMed Web of Science ®Google Scholar
• N. Boechat, V. F. Ferreira, S. B. Ferreira, M. L. G. Ferreira, F. C. da Silva, M. M. Bastos, M. S. Costa, M. C. S. Lourenco, A. C. Pinto, A. U. Krettli, et al. “Novel 1,2,3-Triazole Derivatives for Use against mycobacterium tuberculosis H37Rv (ATCC 27294) Strain,” Journal of Medicinal Chemistry 54, no. 17 (2011): 5988–5999. doi:10.1021/jm2003624
   PubMed Web of Science ®Google Scholar
• Abdul Aziz Ali, Dhrubajyoti Gogoi, Amrita K. Chaliha, Alak K. Buragohain, Priyanka Trivedi, Prakash J. Saikia, Praveen S. Gehlot, Arvind Kumar, Vinita Chaturvedi, and Diganta Sarma, “Synthesis and Biological Evaluation of Novel 1,2,3-Triazole Derivatives as anti-Tubercular Agents,” Bioorganic & Medicinal Chemistry Letters 27, no. 16 (2017): 3698–3703. doi:10.1016/j.bmcl.2017.07.008
   PubMed Web of Science ®Google Scholar
• A. Kamal, S. M. A. Hussaini, S. Faazil, Y. Poornachandra, G. N. Reddy, C. G. Kumar, V. S. Rajput, C. Rani, R. Sharma, I. A. Khan, et al. “Anti-Tubercular Agents. Part 8: Synthesis, Antibacterial and Antitubercular Activity of 5-Nitrofuran Based 1,2,3-Triazoles,” Bioorganic & Medicinal Chemistry Letters 23, no. 24 (2013): 6842–6846. doi:10.1016/j.bmcl.2013.10.010
   PubMed Web of Science ®Google Scholar
• T. R. Deshmukh, S. P. Khare, V. S. Krishna, D. Sriram, J. N. Sangshetti, V. M. Khedkar, and B. B. Shingate, “Synthesis, Bioevaluation and Molecular Docking Study of New Piperazine and Amide Linked Dimeric 1,2,3-Triazoles,” Synthetic Communications 50, no. 2 (2020): 271–288. doi:10.1080/00397911.2019.1695275
   Web of Science ®Google Scholar
• Pramod S. Phatak, Rajubai D. Bakale, Ravibhushan S. Kulkarni, Sambhaji T. Dhumal, Prashant P. Dixit, Vagolu Siva Krishna, Dharmarajan Sriram, Vijay M. Khedkar, and Kishan P. Haval, “Design and Synthesis of New Indanol-1, 2, 3-Triazole Derivatives as Potent Antitubercular and Antimicrobial Agents,” Bioorganic & Medicinal Chemistry Letters 30, no. 22 (2020): 127579. doi:10.1016/j.bmcl.2020.127579
   PubMed Web of Science ®Google Scholar
• P. S. Pathak, B. P. Sathe, S. T. Dhumal, N. M. A. Naziya, P. P. Dixit, P. B. Choudhari, V. S. Krishna, D. Sriram, and K. P. Haval, “Synthesis, Antimicrobial Evaluation, and Docking Studies of Substituted Acetylphenoxymethyl‐Triazolyl‐N‐Phenylacetamides,” Journal of Heterocyclic Chemistry 56, no. 7 (2019): 1928–1938. doi:10.1002/jhet.3568
   Web of Science ®Google Scholar
• Jurupula Ramprasad, Vinay Kumar Sthalam, Rama Linga Murthy Thampunuri, Supriya Bhukya, Ramesh Ummanni, Sridhar Balasubramanian, and Srihari Pabbaraja, “Synthesis and Evaluation of a Novel Quinoline-Triazole Analogs for Antitubercular Properties via Molecular Hybridization Approach,” Bioorganic & Medicinal Chemistry Letters 29, no. 20 (2019): 126671. doi:10.1016/j.bmcl.2019.126671
   PubMed Web of Science ®Google Scholar
• Mahesh B. Muluk, Sambhaji T. Dhumal, Pramod S. Phatak, Naziya N. M. A. Rehman, Prashant P. Dixit, Prafulla B. Choudhari, Ramrao A. Mane, and Kishan P. Haval, “Synthesis, Antimicrobial Activity, and Molecular Docking Study of Formylnaphthalenyloxymethyl‐Triazolyl‐N‐Phenylacetamides,” Journal of Heterocyclic Chemistry 56, no. 9 (2019): 2411–2418. doi:10.1002/jhet.3628
   Web of Science ®Google Scholar
• Pramod S. Phatak, Rajubai D. Bakale, Sambhaji T. Dhumal, Lalita K. Dahiwade, Prafulla B. Choudhari, Vagolu Siva Krishna, Dharmarajan Sriram, and Kishan P. Haval, “Synthesis, Antitubercular Evaluation and Molecular Docking Studies of Phthalimide Bearing 1,2,3-Triazoles,” Synthetic Communications 49, no. 16 (2019): 2017–2028. doi:10.1080/00397911.2019.1614630
   Web of Science ®Google Scholar
• I. Mancini, A. Sicurelli, G. Guella, T. Turk, P. Macek, and K. Sepcic, “Synthesis and Bioactivity of Linear Oligomers Related to Polymeric Alkylpyridinium Metabolites from the Mediterranean Sponge Reniera Sarai,” Organic & Biomolecular Chemistry 2, no. 9 (2004): 1368–1375. doi:10.1039/b400782d
   PubMed Web of Science ®Google Scholar
• C. Vilchèze, H. R. Morbidoni, T. R. Weisbrod, H. Iwamoto, M. Kuo, J. C. Sacchettini, and W. R. Jacobs, “Inactivation of the inhA-Encoded Fatty Acid Synthase II (FASII) Enoyl-Acyl Carrier Protein Reductase Induces Accumulation of the FASI End Products and Cell Lysis of Mycobacterium smegmatis,” Journal of Bacteriology 182, no. 14 (2000): 4059–4067. doi:10.1128/JB.182.14.4059-4067.2000
   PubMed Web of Science ®Google Scholar
• C. Menendez, S. Gau, C. Lherbet, F. Rodriguez, C. Inard, M. R. Pasca, and M. Baltas, “Synthesis and Biological Activities of Triazole Derivatives as Inhibitors of InhA and Antituberculosis Agents,” European Journal of Medicinal Chemistry 46, no. 11 (2011): 5524–5531. doi:10.1016/j.ejmech.2011.09.013
   PubMed Web of Science ®Google Scholar
• C. Menendez, A. Chollet, F. Rodriguez, C. Inard, M. R. Pasca, C. Lherbet, and M. Baltas, “Chemical Synthesis and Biological Evaluation of Triazole Derivatives as Inhibitors of InhA and Antituberculosis Agents,” European Journal of Medicinal Chemistry 52 (2012): 275–283. doi:10.1016/j.ejmech.2012.03.029
   PubMed Web of Science ®Google Scholar
• K. D. Asgaonkar, G. D. Mote, and T. S. Chitre, “QSAR and Molecular Docking Studies of Oxadiazole-Ligated Pyrrole Derivatives as enoyl-ACP (CoA) Reductase Inhibitors,” Scientia Pharmaceutica 82, no. 1 (2014): 71–85. doi:10.3797/scipharm.1310-05
   PubMedGoogle Scholar
• S. G. Kini, A. R. Bhat, B. Bryant, J. S. Williamson, and F. E. Dayan, “Synthesis, Antitubercular Activity and Docking Study of Novel Cyclic Azole Substituted Diphenyl Ether Derivatives,” European Journal of Medicinal Chemistry 44, no. 2 (2009): 492–500. doi:10.1016/j.ejmech.2008.04.013
   PubMed Web of Science ®Google Scholar
• B. Mathew, J. Suresh, G. E. Mathew, G. Sonia, and G. K. Krishan, “Design, Synthesis, Toxicity Estimation and Molecular Docking Studies of N-(Furan-2-yl)-1-(5-Substituted) Phenyl-1,3,4-Oxadiazol-2-yl) Methanimine as Antitubercular Agents,” Indian Jounal of Pharmaceutical Sciences 76 (2014): 401–406.
   PubMed Web of Science ®Google Scholar
• Schrodinger, LLC: New York, NY, 2015.
   Google Scholar
• R. A. Friesner, R. B. Murphy, M. P. Repasky, L. L. Frye, J. R. Greenwood, T. A. Halgren, P. C. Sanschagrin, and D. T. Mainz, “Extra Precision Glide: Docking and Scoring Incorporating a Model of Hydrophobic Enclosure for Protein-Ligand Complexes,” Journal of Medicinal Chemistry 49, no. 21 (2006): 6177–6196. doi:10.1021/jm051256o
   PubMed Web of Science ®Google Scholar
• R. A. Friesner, J. L. Banks, R. B. Murphy, T. A. Halgren, J. J. Klicic, D. T. Mainz, M. P. Repasky, E. H. Knoll, M. Shelley, J. K. Perry, et al. “New Approach for Rapid, Accurate Docking and Scoring. 1. Method and Assessment of Docking Accuracy,” Journal of Medicinal Chemistry 47, no. 7 (2004): 1739–1749. doi:10.1021/jm0306430
   PubMed Web of Science ®Google Scholar
• T. A. Halgren, R. B. Murphy, R. A. Friesner, H. S. Beard, L. L. Frye, W. T. Pollard, and J. L. Banks, “Glide: A New Approach for Rapid, Accurate Docking and Scoring.2. Enrichment Factors in Database Screening,” Journal of Medicinal Chemistry 47, no. 7 (2004): 1750–1759. doi:10.1021/jm030644s
   PubMed Web of Science ®Google Scholar
• A. B. Danne, A. S. Choudhari, S. Chakraborty, D. Sarkar, V. M. Khedkar, and B. B. Shingate, “Triazole-Diindolylmethane Conjugates as New Antitubercular Agents: Synthesis, Bioevaluation, and Molecular Docking,” MedChemComm 9, no. 7 (2018): 1114–1130. doi:10.1039/c8md00055g
   PubMed Web of Science ®Google Scholar
• C. A. Lipinski, L. Lombardo, B. W. Dominy, and P. J. Feeney, “Experimental and Computational Approaches to Estimate Solubility and Permeability in Drug Discovery and Development Settings,” Advanced Drug Delivery Reviews 46, no. 1-3 (2001): 3–26. doi:10.1016/s0169-409x(00)00129-0
   PubMed Web of Science ®Google Scholar
• Molinspiration Chemoinformatics Brastislava, Slovak Republic. 2014. http://www.molinspiration.com/cgi-bin/properties
   Google Scholar
• Yuan H. Zhao, Michael H. Abraham, Joelle Le, Anne Hersey, Chris N. Luscombe, Gordon Beck, Brad Sherborne, and Ian Cooper, “Rate-Limited Steps of Human Oral Absorption and QSAR Studies,” Pharmaceutical Research 19, no. 10 (2002): 1446–1457. doi:10.1023/a:1020444330011
   PubMed Web of Science ®Google Scholar
• MOLSOFT. Drug-likeness and molecular property prediction. http://www.molsoft.com/mprop. Accessed on 10 April 2020
   Google Scholar